Boston Scientific reports $298M Q1 profit
Courtesy | Boston Scientific
Boston Scientific's global headquarters are located in Marlborough.
Medical device giant Boston Scientific continues to run like a well-oiled machine, reporting first quarter net income of $298 million on revenues of nearly $2.4 billion.
Both marks are improvements over lthe Marlborough-based company's 2017 first-quarter results of of $290 million and $2.1 billion, respectively.
In all segments, the company claimed reported growth of at least 9.5 percent, and the company grew its business abroad by at least 12 percent reported.
U.S. growth was 4.8 percent, while the company reported growth of 24 percent in Europe, Middle East and Africa.
Asia-Pacific growth was 12 percent, and 22.6 percent reported in emerging markets.
"Our consistently strong performance reflects our team's ongoing dedication to patients and customers," said Mike Mahoney, chairman and CEO. "With our increasingly diversified portfolio and resilience in a rapidly-evolving global landscape, we are excited about our outlook."
It’s been a busy 12 months for the company which has acquired six companies over that span for what could eventually total more than $1 billion if some contingencies are met.
Boston Scientific this year created a new segment, which combines its cardiac rhythm management, electrophysiology and neuromodulation segments in an effort to focus on active implantable devices.
Read more
Three Central Mass. companies pay top exec at least 100 times higher than median employee
WBJ Web Partners
Most Recent
Most Recent
0 Comments